Table of Contents

1 Report Business Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Live Biotherapeutic Products Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 Solids
  • 1.2.3 Oral Liquids
  • 1.2.4 Injectables
  • 1.2.5 Others
• 1.3 Market by Application
  • 1.3.1 Global Live Biotherapeutic Products Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Autoimmune Disease
  • 1.3.3 Digestive System Diseases
  • 1.3.4 Infectious Disease
  • 1.3.5 Metabolic Disease
  • 1.3.6 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Live Biotherapeutic Products Market Perspective (2017-2028)
• 2.2 Live Biotherapeutic Products Growth Trends by Region
  • 2.2.1 Live Biotherapeutic Products Market Size by Region: 2017 VS 2021 VS 2028
  • 2.2.2 Live Biotherapeutic Products Historic Market Size by Region (2017-2022)
  • 2.2.3 Live Biotherapeutic Products Forecasted Market Size by Region (2023-2028)
• 2.3 Live Biotherapeutic Products Market Dynamics
  • 2.3.1 Live Biotherapeutic Products Industry Trends
  • 2.3.2 Live Biotherapeutic Products Market Drivers
  • 2.3.3 Live Biotherapeutic Products Market Challenges
  • 2.3.4 Live Biotherapeutic Products Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Live Biotherapeutic Products Players by Revenue
  • 3.1.1 Global Top Live Biotherapeutic Products Players by Revenue (2017-2022)
  • 3.1.2 Global Live Biotherapeutic Products Revenue Market Share by Players (2017-2022)
• 3.2 Global Live Biotherapeutic Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Players Covered: Ranking by Live Biotherapeutic Products Revenue
• 3.4 Global Live Biotherapeutic Products Market Concentration Ratio
  • 3.4.1 Global Live Biotherapeutic Products Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Live Biotherapeutic Products Revenue in 2021
• 3.5 Live Biotherapeutic Products Key Players Head office and Area Served
• 3.6 Key Players Live Biotherapeutic Products Product Solution and Service
• 3.7 Date of Enter into Live Biotherapeutic Products Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Live Biotherapeutic Products Breakdown Data by Type

• 4.1 Global Live Biotherapeutic Products Historic Market Size by Type (2017-2022)
• 4.2 Global Live Biotherapeutic Products Forecasted Market Size by Type (2023-2028)

5 Live Biotherapeutic Products Breakdown Data by Application

• 5.1 Global Live Biotherapeutic Products Historic Market Size by Application (2017-2022)
• 5.2 Global Live Biotherapeutic Products Forecasted Market Size by Application (2023-2028)

6 North America

• 6.1 North America Live Biotherapeutic Products Market Size (2017-2028)
• 6.2 North America Live Biotherapeutic Products Market Size by Type
  • 6.2.1 North America Live Biotherapeutic Products Market Size by Type (2017-2022)
  • 6.2.2 North America Live Biotherapeutic Products Market Size by Type (2023-2028)
  • 6.2.3 North America Live Biotherapeutic Products Market Share by Type (2017-2028)
• 6.3 North America Live Biotherapeutic Products Market Size by Application
  • 6.3.1 North America Live Biotherapeutic Products Market Size by Application (2017-2022)
  • 6.3.2 North America Live Biotherapeutic Products Market Size by Application (2023-2028)
  • 6.3.3 North America Live Biotherapeutic Products Market Share by Application (2017-2028)
• 6.4 North America Live Biotherapeutic Products Market Size by Country
  • 6.4.1 North America Live Biotherapeutic Products Market Size by Country (2017-2022)
  • 6.4.2 North America Live Biotherapeutic Products Market Size by Country (2023-2028)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Live Biotherapeutic Products Market Size (2017-2028)
• 7.2 Europe Live Biotherapeutic Products Market Size by Type
  • 7.2.1 Europe Live Biotherapeutic Products Market Size by Type (2017-2022)
  • 7.2.2 Europe Live Biotherapeutic Products Market Size by Type (2023-2028)
  • 7.2.3 Europe Live Biotherapeutic Products Market Share by Type (2017-2028)
• 7.3 Europe Live Biotherapeutic Products Market Size by Application
  • 7.3.1 Europe Live Biotherapeutic Products Market Size by Application (2017-2022)
  • 7.3.2 Europe Live Biotherapeutic Products Market Size by Application (2023-2028)
  • 7.3.3 Europe Live Biotherapeutic Products Market Share by Application (2017-2028)
• 7.4 Europe Live Biotherapeutic Products Market Size by Country
  • 7.4.1 Europe Live Biotherapeutic Products Market Size by Country (2017-2022)
  • 7.4.2 Europe Live Biotherapeutic Products Market Size by Country (2023-2028)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic Countries

8 Asia-Pacific

• 8.1 Asia-Pacific Live Biotherapeutic Products Market Size (2017-2028)
• 8.2 Asia-Pacific Live Biotherapeutic Products Market Size by Type
  • 8.2.1 Asia-Pacific Live Biotherapeutic Products Market Size by Type (2017-2022)
  • 8.2.2 Asia-Pacific Live Biotherapeutic Products Market Size by Type (2023-2028)
  • 8.2.3 Asia-Pacific Live Biotherapeutic Products Market Share by Type (2017-2028)
• 8.3 Asia-Pacific Live Biotherapeutic Products Market Size by Application
  • 8.3.1 Asia-Pacific Live Biotherapeutic Products Market Size by Application (2017-2022)
  • 8.3.2 Asia-Pacific Live Biotherapeutic Products Market Size by Application (2023-2028)
  • 8.3.3 Asia-Pacific Live Biotherapeutic Products Market Share by Application (2017-2028)
• 8.4 Asia-Pacific Live Biotherapeutic Products Market Size by Region
  • 8.4.1 Asia-Pacific Live Biotherapeutic Products Market Size by Region (2017-2022)
  • 8.4.2 Asia-Pacific Live Biotherapeutic Products Market Size by Region (2023-2028)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Live Biotherapeutic Products Market Size (2017-2028)
• 9.2 Latin America Live Biotherapeutic Products Market Size by Type
  • 9.2.1 Latin America Live Biotherapeutic Products Market Size by Type (2017-2022)
  • 9.2.2 Latin America Live Biotherapeutic Products Market Size by Type (2023-2028)
  • 9.2.3 Latin America Live Biotherapeutic Products Market Share by Type (2017-2028)
• 9.3 Latin America Live Biotherapeutic Products Market Size by Application
  • 9.3.1 Latin America Live Biotherapeutic Products Market Size by Application (2017-2022)
  • 9.3.2 Latin America Live Biotherapeutic Products Market Size by Application (2023-2028)
  • 9.3.3 Latin America Live Biotherapeutic Products Market Share by Application (2017-2028)
• 9.4 Latin America Live Biotherapeutic Products Market Size by Country
  • 9.4.1 Latin America Live Biotherapeutic Products Market Size by Country (2017-2022)
  • 9.4.2 Latin America Live Biotherapeutic Products Market Size by Country (2023-2028)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Live Biotherapeutic Products Market Size (2017-2028)
• 10.2 Middle East & Africa Live Biotherapeutic Products Market Size by Type
  • 10.2.1 Middle East & Africa Live Biotherapeutic Products Market Size by Type (2017-2022)
  • 10.2.2 Middle East & Africa Live Biotherapeutic Products Market Size by Type (2023-2028)
  • 10.2.3 Middle East & Africa Live Biotherapeutic Products Market Share by Type (2017-2028)
• 10.3 Middle East & Africa Live Biotherapeutic Products Market Size by Application
  • 10.3.1 Middle East & Africa Live Biotherapeutic Products Market Size by Application (2017-2022)
  • 10.3.2 Middle East & Africa Live Biotherapeutic Products Market Size by Application (2023-2028)
  • 10.3.3 Middle East & Africa Live Biotherapeutic Products Market Share by Application (2017-2028)
• 10.4 Middle East & Africa Live Biotherapeutic Products Market Size by Country
  • 10.4.1 Middle East & Africa Live Biotherapeutic Products Market Size by Country (2017-2022)
  • 10.4.2 Middle East & Africa Live Biotherapeutic Products Market Size by Country (2023-2028)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Capsugel
  • 11.1.1 Capsugel Company Details
  • 11.1.2 Capsugel Business Overview
  • 11.1.3 Capsugel Live Biotherapeutic Products Introduction
  • 11.1.4 Capsugel Revenue in Live Biotherapeutic Products Business (2017-2022)
  • 11.1.5 Capsugel Recent Developments
• 11.2 Jeneil Biotech
  • 11.2.1 Jeneil Biotech Company Details
  • 11.2.2 Jeneil Biotech Business Overview
  • 11.2.3 Jeneil Biotech Live Biotherapeutic Products Introduction
  • 11.2.4 Jeneil Biotech Revenue in Live Biotherapeutic Products Business (2017-2022)
  • 11.2.5 Jeneil Biotech Recent Developments
• 11.3 UAS Labs
  • 11.3.1 UAS Labs Company Details
  • 11.3.2 UAS Labs Business Overview
  • 11.3.3 UAS Labs Live Biotherapeutic Products Introduction
  • 11.3.4 UAS Labs Revenue in Live Biotherapeutic Products Business (2017-2022)
  • 11.3.5 UAS Labs Recent Developments
• 11.4 Biose
  • 11.4.1 Biose Company Details
  • 11.4.2 Biose Business Overview
  • 11.4.3 Biose Live Biotherapeutic Products Introduction
  • 11.4.4 Biose Revenue in Live Biotherapeutic Products Business (2017-2022)
  • 11.4.5 Biose Recent Developments
• 11.5 Cerbios-Pharma
  • 11.5.1 Cerbios-Pharma Company Details
  • 11.5.2 Cerbios-Pharma Business Overview
  • 11.5.3 Cerbios-Pharma Live Biotherapeutic Products Introduction
  • 11.5.4 Cerbios-Pharma Revenue in Live Biotherapeutic Products Business (2017-2022)
  • 11.5.5 Cerbios-Pharma Recent Developments
• 11.6 Inpac Probiotics
  • 11.6.1 Inpac Probiotics Company Details
  • 11.6.2 Inpac Probiotics Business Overview
  • 11.6.3 Inpac Probiotics Live Biotherapeutic Products Introduction
  • 11.6.4 Inpac Probiotics Revenue in Live Biotherapeutic Products Business (2017-2022)
  • 11.6.5 Inpac Probiotics Recent Developments
• 11.7 NIZO
  • 11.7.1 NIZO Company Details
  • 11.7.2 NIZO Business Overview
  • 11.7.3 NIZO Live Biotherapeutic Products Introduction
  • 11.7.4 NIZO Revenue in Live Biotherapeutic Products Business (2017-2022)
  • 11.7.5 NIZO Recent Developments
• 11.8 Winclove Probiotics
  • 11.8.1 Winclove Probiotics Company Details
  • 11.8.2 Winclove Probiotics Business Overview
  • 11.8.3 Winclove Probiotics Live Biotherapeutic Products Introduction
  • 11.8.4 Winclove Probiotics Revenue in Live Biotherapeutic Products Business (2017-2022)
  • 11.8.5 Winclove Probiotics Recent Developments
• 11.9 BJP Laboratories
  • 11.9.1 BJP Laboratories Company Details
  • 11.9.2 BJP Laboratories Business Overview
  • 11.9.3 BJP Laboratories Live Biotherapeutic Products Introduction
  • 11.9.4 BJP Laboratories Revenue in Live Biotherapeutic Products Business (2017-2022)
  • 11.9.5 BJP Laboratories Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Author Details

Summary:

Market Analysis and Insights: Global Live Biotherapeutic Products Market
The global Live Biotherapeutic Products market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Solids accounting for % of the Live Biotherapeutic Products global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Autoimmune Disease segment is altered to an % CAGR throughout this forecast period.
China Live Biotherapeutic Products market size is valued at US$ million in 2021, while the North America and Europe Live Biotherapeutic Products are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Live Biotherapeutic Products landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Live Biotherapeutic Products market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Live Biotherapeutic Products market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Live Biotherapeutic Products market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Live Biotherapeutic Products market.
Impact of Covid-19 Outbreak
This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.
Segmental Analysis
The report has been segmented into product and application segments. The researchers have documented all the products present today in the Live Biotherapeutic Products market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.
Live Biotherapeutic Products Breakdown Data by Type
Solids
Oral Liquids
Injectables
Others
Live Biotherapeutic Products Breakdown Data by Application
Autoimmune Disease
Digestive System Diseases
Infectious Disease
Metabolic Disease
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Competitive Landscape
This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:
Capsugel
Jeneil Biotech
UAS Labs
Biose
Cerbios-Pharma
Inpac Probiotics
NIZO
Winclove Probiotics
BJP Laboratories
Frequently Asked Questions
What factors will challenge the Live Biotherapeutic Products market growth?
Which end-use segment will expand at the fastest CAGR in the Live Biotherapeutic Products market?
Which are the emerging players in the Live Biotherapeutic Products market?
How concentrated is the Live Biotherapeutic Products market?
Which factors are positively contributing to the Live Biotherapeutic Products market growth?
Which are the novel product innovations in the Live Biotherapeutic Products market?
Which product segment will emerge as the most lucrative in the Live Biotherapeutic Products market?
Which factors are increasing the competition in the Live Biotherapeutic Products market?
Which are the strategic measures taken by the Live Biotherapeutic Products industry players?
Which region will witness inactive growth during the forecast period?
What key trends are likely to emerge in the Live Biotherapeutic Products market in the coming years?